Patient Education - Endocrine Encyclopedia
Endocrine Surgery Encyclopedia
Definition:
A prolactinoma is a noncancerous pituitary tumor that causes excess secretion of
the hormone prolactin. Prolactin is a hormone that causes secretion of milk from
the breasts during nursing. It is also involved in the control of sexual desire.
Alternative Names: Prolactinoma - females; Adenoma - secreting
Causes, incidence, and risk factors:
Prolactin is a hormone that induces lactation or milk production. The size of the
prolactinoma correlates with the excess prolactin level; the larger the tumor, the
higher the level of prolactin that is secreted.
Prolactinoma is the most common type of pituitary adenoma and is also referred
to as a prolactin-secreting adenoma of the pituitary. These tumors account for at
least 30% of all pituitary adenomas.
At least half of all prolactinomas are microadenomas. Microprolactinomas are more
common in women. Larger tumors, called macroprolactinomas, are more common in men.
Many of the smaller tumors do not progress to larger tumors.
Prolactinomas occur most commonly in those under 40 years old. They are rare in
children. These tumors are about fives times as common in women as men. In women,
prolactinomas typically cause amenorrhea (lack of menstruation) and galactorrhea
(milk production from the breasts, not associated with pregnancy) and occur in young
patients. By contrast, prolactinomas in men occur in older patients and can grow
to a large size before any symptoms occur.
Symptoms:
In women:
- Cessation of menses not related to menopause
- Abnormal milk flow from the breast not related to nursing or childbirth (galactorrhea)
- Infertility
- Decreased sexual interest
- headache
- visual changes
In men:
- Enlargement of breast tissue (gynecomastia)
- Infertility
- Impotence
- Decreased sexual interest
- headache
- visual changes
Note: there may be no symptoms, particularly in men.
Signs and tests:
- Prolactin levels
- Cranial MRI or cranial CT scan that shows a pituitary mass
- Decreased testosterone levels in men
Treatment:
In women, the symptoms of infertility, irregular menstruation, loss of sexual interest,
and milk flow not related to childbirth or nursing can be improved with treatment.
Men should be treated when decreased sexual drive, infertility, or impotence occur.
Bromocriptine, pergolide, and cabergoline are drugs that reduce prolactin levels
in both men and women. Once started, these drugs must be continued for life. If the
drug is stopped, the tumor will rapidly grow back. Most people respond to these drugs,
although failure is more likely with large prolactinomas.
Using bromocriptine over time can reduce the chance of a cure using surgical removal.
Therefore, if surgery is to be done, it is best to perform the surgery during the
first 6 months of using this drug.
Surgery may be needed in the case of a prolactinoma that is not controlled by
medication, and in patients who have trouble tolerating medication side effects.
Radiotherapy (conventional radiation or gamma knife) is usually for patients who
have persistent and progressive (worsening) prolactinoma after trying both medication
and surgery.
Support Groups:
Expectations (prognosis):
The outlook depends heavily on the success of medical and surgical therapies. Tests
to scan for recurrence following treatment are important.
Complications:
Tumor regrowth is the main complication. If untreated, tumor growth may result in
permanent vision loss, including blindness, because large tumors in this area often
press on the nerves involved in vision.
Calling your health care provider:
See your health care provider if symptoms suggestive of prolactinoma develop.
If you have had a prolactinoma in the past, call your health care provider if
you experience recurrence of the symptoms.
Prevention:
Review Date: 11/5/2004
Reviewed By: Luc D. Jasmin, M.D., Ph.D., Department of Neurological Surgery, University
of California, San Francisco, CA. Review provided by VeriMed Healthcare Network.
 A.D.A.M.,
Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission
(www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M.
follows rigorous standards of quality and accountability. A.D.A.M. is among the first to
achieve this important distinction for online health information and services. Learn more
about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also
a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net
Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for
the diagnosis or treatment of any medical condition. A licensed medical professional should
be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for
all medical emergencies. Links to other sites are provided for information only -- they do
not constitute endorsements of those other sites. © 1997- 2007 A.D.A.M., Inc. Any duplication
or distribution of the information contained herein is strictly prohibited.
|
